OBJECTIVES: Argon plasma coagulation (APC), performed as an outpatient procedure, is used to treat severe allergic rhinitis (AR) that is unresponsive to drug therapy. The purpose of this study was to determine the therapeutic effects of APC on patients with perennial AR (PAR) or seasonal AR (pollinosis), and to confirm complications after APC.
Change of the inferior turbinate on patient with PAR after APC The inferior turbinate edema and the quantify of nasal discharge in the 4 PAR cases improved after APC.
Diachronic curative effect of APC for pollinosis 40-60% improvement in the 3 nasal symptoms was observed for 3 seasons after APC. The mean VAS scores of the 3 nasal symptoms, especially nasal obstruction, remained significantly improved for 1 season between before and after APC (P < 0.05).
Diachronic curative effect of APC for PAR The mean VAS scores of nasal discharge, sneezing and especially nasal obstruction remained significantly improved for 3 months after APC (P < 0.05).
